Walleye Capital’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-77,700
Closed -$22K 3437
2022
Q2
$22K Sell
77,700
-87,505
-53% -$56.3K ﹤0.01% 1894
2022
Q1
$133K Buy
165,205
+2,100
+1% +$2.12K ﹤0.01% 1668
2021
Q4
$308K Hold
163,105
0.01% 1240
2021
Q3
$418 Hold
163,105
0.01% 860
2021
Q2
$424 Hold
163,105
0.01% 821
2021
Q1
$435 Buy
+163,105
New +$472K 0.03% 630

Other funds holding NUVB.WS

Walleye Capital's NUVB.WS Position: Q3 2022 in Review

Walleye Capital sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q3 2022, closing a stake of 77,700 shares — an estimated $22K sold.

Walleye Capital first reported a position in NUVB.WS in Q1 2021 and held it in 6 quarters. The position peaked at $308K in Q4 2021. 20 funds tracked by Wall St. Rank hold NUVB.WS as of Q3 2022.

  • Walleye Capital reported no remaining Nuvation Bio Inc Warrants position as of Q3 2022 after selling out during the quarter.
  • Walleye Capital sold 77,700 Nuvation Bio Inc Warrants shares in Q3 2022, an estimated $22K.
  • Walleye Capital first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 6 quarters.
  • Walleye Capital's Nuvation Bio Inc Warrants position peaked at $308K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q3 2022.

Based on Walleye Capital's 13F filing for Q3 2022, filed 14 Nov 2022.